Oklahoma Medical Marijuana Recall Issued Over Mold and Yeast
Oklahoma Medical Marijuana Recall Issued After Products Fail Mold and Yeast Testing
Oklahoma medical marijuana patients are being urged to check their purchases after state regulators issued a new recall involving cannabis flower that failed required safety testing. The Oklahoma Medical Marijuana Authority (OMMA) announced the recall on Tuesday, October 20, identifying two production batches originating from Blue Collar Criminals Collective, LLC. The products had already been transferred to licensed dispensaries before regulators confirmed the testing failures, raising concerns about potentially contaminated marijuana reaching patients.
The Oklahoma medical marijuana recall involves flower products that failed laboratory testing for yeast and mold, contaminants that can present health concerns when inhaled, particularly for patients with weakened immune systems or existing respiratory conditions. State investigators traced the affected inventory through Oklahoma's marijuana tracking system and identified dispensaries and patient transactions associated with the recalled batches. Officials are now directing businesses to remove the products from sale while encouraging patients to verify batch numbers before consuming marijuana they have already purchased.
Oklahoma Medical Marijuana Recall Involves Two Contaminated Flower Batches
According to the Oklahoma Medical Marijuana Authority's official recall notice, the affected products originated from Blue Collar Criminals Collective, LLC, a licensed Oklahoma marijuana grow operation identified by license number GAAI-NJVE-0Z9P. The recall followed separate reports submitted by the originating grow facility and a licensed dispensary, prompting regulators to investigate laboratory results and determine which products may have entered the retail market.
OMMA's Office of Investigation and Enforcement reviewed testing records and used Metrc, Oklahoma's statewide marijuana inventory tracking system, to trace the affected batches through the distribution process. The investigation identified dispensaries that received the products and patient transactions connected to the recalled inventory. That tracking information allows regulators and licensed businesses to determine where potentially contaminated marijuana was distributed and which purchases may require additional notification.
Yeast and mold testing is an important component of Oklahoma's medical marijuana safety requirements because cannabis products can develop microbial contamination during cultivation, harvesting, processing or storage. Mold exposure may be particularly concerning for patients with respiratory illnesses or compromised immune systems. However, a failed microbial test does not establish that every patient who purchased an affected product has experienced an adverse health reaction.
The recall applies specifically to the two identified production batches, not every product grown or distributed by the originating facility. Patients should examine the batch information printed on their marijuana packaging and compare it with the official OMMA recall notice. Product names alone may not be sufficient to determine whether a particular purchase is affected.
Oklahoma Introduces New Marijuana Recall Alerts Through State Tracking System
Alongside the recall announcement, OMMA introduced a new inventory notification feature intended to help marijuana businesses identify recalled products more quickly. Effective October 20, affected production batches and related packages will display a warning symbol and administrative recall alert within the state's Metrc tracking system. The feature is designed to provide an additional safeguard against recalled products remaining available for purchase.
Metrc is used to track medical marijuana inventory as products move through Oklahoma's regulated cannabis industry, from cultivation and processing to dispensary sales. By incorporating recall warnings directly into that system, regulators aim to make affected inventory easier for licensed businesses to recognize during routine inventory management and compliance reviews. OMMA says the notification feature will also be used for future recalls.
Dispensaries that possess affected inventory must remove recalled products from their shelves and prevent further sales. Commercial licensees are also responsible for following applicable recall procedures, including notifying affected businesses and patients and ensuring products are handled according to state requirements. These responsibilities are particularly important when recalled inventory has already moved through multiple licensed businesses before a safety issue is identified.
The new tracking feature represents an additional layer of oversight for an industry in which product safety depends on accurate laboratory testing, inventory records and communication between regulators and licensed operators. While the technology may help businesses identify recalled products, it does not replace their responsibility to monitor official notices and comply with state regulations.
Medical Marijuana Patients Urged to Check Purchases and Report Health Concerns
Patients who purchased marijuana flower associated with Blue Collar Criminals Collective, LLC should review their packaging and verify whether the batch number matches either of the recalled production batches. Anyone possessing an affected product should stop using it immediately and contact the dispensary where it was purchased for information about the recall. OMMA also advises patients that recalled products may be disposed of rather than consumed.
Patients who believe they experienced an adverse health reaction after using medical marijuana can contact a healthcare professional and report their concerns through OMMA's official Health Impact Form. Providing accurate product information, including packaging details and batch numbers, can help regulators evaluate reports and determine whether additional investigation is necessary.
The agency also encourages patients and members of the public to report dispensaries that continue offering recalled products for sale. Those complaints can be submitted through OMMA's business complaint reporting system. Reports involving recalled inventory can help regulators identify potential compliance violations and prevent additional distribution of products that have failed required safety standards.
For Oklahoma's medical marijuana patients, the recall reinforces the importance of retaining original product packaging and checking official safety announcements. Because recalls may affect only specific production batches, identifying the correct product requires more than recognizing a familiar strain or dispensary name. Accurate batch information remains the most reliable way to determine whether a purchase is included in a recall.
The October 20 announcement does not indicate that every product from the originating grow facility is unsafe, nor does it establish that all patients who purchased the recalled marijuana will experience health problems. The immediate concern is preventing further consumption of products that failed the state's microbial testing requirements.
For patients who rely on medical marijuana, product safety should never be a guessing game. Oklahoma's latest recall is a reminder that testing, accurate tracking and timely notification are essential to protecting the people the state's medical marijuana program was created to serve.
Comments